nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—Dapsone—malaria	0.2	0.55	CbGbCtD
Lenalidomide—ABCB1—Quinine—malaria	0.087	0.239	CbGbCtD
Lenalidomide—ABCB1—Quinidine—malaria	0.0765	0.21	CbGbCtD
Lenalidomide—CDH5—endothelium—malaria	0.0275	0.149	CbGeAlD
Lenalidomide—TNFSF11—hematopoietic system—malaria	0.018	0.0972	CbGeAlD
Lenalidomide—CDH5—hematopoietic system—malaria	0.0135	0.0731	CbGeAlD
Lenalidomide—TNFSF11—blood—malaria	0.0119	0.0644	CbGeAlD
Lenalidomide—TNFSF11—bone marrow—malaria	0.0115	0.0623	CbGeAlD
Lenalidomide—CRBN—saliva-secreting gland—malaria	0.00899	0.0487	CbGeAlD
Lenalidomide—CDH5—blood—malaria	0.00895	0.0484	CbGeAlD
Lenalidomide—CDH5—bone marrow—malaria	0.00866	0.0469	CbGeAlD
Lenalidomide—CRBN—hematopoietic system—malaria	0.00858	0.0464	CbGeAlD
Lenalidomide—Pomalidomide—TNF—malaria	0.0073	0.608	CrCbGaD
Lenalidomide—CDH5—liver—malaria	0.007	0.0379	CbGeAlD
Lenalidomide—CRBN—digestive system—malaria	0.00597	0.0323	CbGeAlD
Lenalidomide—CRBN—blood—malaria	0.00568	0.0308	CbGeAlD
Lenalidomide—CDH5—brain—malaria	0.00555	0.03	CbGeAlD
Lenalidomide—CRBN—bone marrow—malaria	0.0055	0.0298	CbGeAlD
Lenalidomide—PTGS2—endothelium—malaria	0.00476	0.0257	CbGeAlD
Lenalidomide—Thalidomide—TNF—malaria	0.00471	0.392	CrCbGaD
Lenalidomide—CRBN—liver—malaria	0.00444	0.0241	CbGeAlD
Lenalidomide—PTGS2—blood plasma—malaria	0.00422	0.0229	CbGeAlD
Lenalidomide—CRBN—brain—malaria	0.00353	0.0191	CbGeAlD
Lenalidomide—ABCB1—blood plasma—malaria	0.00261	0.0141	CbGeAlD
Lenalidomide—PTGS2—hematopoietic system—malaria	0.00234	0.0126	CbGeAlD
Lenalidomide—PTGS2—kidney—malaria	0.00191	0.0104	CbGeAlD
Lenalidomide—PTGS2—digestive system—malaria	0.00162	0.00879	CbGeAlD
Lenalidomide—PTGS2—blood—malaria	0.00155	0.00838	CbGeAlD
Lenalidomide—PTGS2—bone marrow—malaria	0.0015	0.00811	CbGeAlD
Lenalidomide—ABCB1—hematopoietic system—malaria	0.00144	0.00782	CbGeAlD
Lenalidomide—PTGS2—liver—malaria	0.00121	0.00655	CbGeAlD
Lenalidomide—ABCB1—kidney—malaria	0.00118	0.00641	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—CRP—malaria	0.00103	0.106	CbGpPWpGaD
Lenalidomide—ABCB1—digestive system—malaria	0.001	0.00544	CbGeAlD
Lenalidomide—PTGS2—brain—malaria	0.00096	0.0052	CbGeAlD
Lenalidomide—ABCB1—blood—malaria	0.000957	0.00518	CbGeAlD
Lenalidomide—ABCB1—bone marrow—malaria	0.000926	0.00501	CbGeAlD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—ICAM1—malaria	0.000833	0.0858	CbGpPWpGaD
Lenalidomide—ABCB1—liver—malaria	0.000749	0.00405	CbGeAlD
Lenalidomide—ABCB1—brain—malaria	0.000594	0.00322	CbGeAlD
Lenalidomide—Muscle spasms—Clindamycin—malaria	0.000558	0.0013	CcSEcCtD
Lenalidomide—CDH5—Signaling events mediated by VEGFR1 and VEGFR2—KDR—malaria	0.000556	0.0573	CbGpPWpGaD
Lenalidomide—Decreased appetite—Sulfadiazine—malaria	0.000553	0.00128	CcSEcCtD
Lenalidomide—Eye disorder—Quinidine barbiturate—malaria	0.000551	0.00128	CcSEcCtD
Lenalidomide—Tinnitus—Quinidine barbiturate—malaria	0.00055	0.00128	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Sulfadiazine—malaria	0.000549	0.00128	CcSEcCtD
Lenalidomide—Flushing—Quinidine barbiturate—malaria	0.000548	0.00127	CcSEcCtD
Lenalidomide—Cardiac disorder—Quinidine barbiturate—malaria	0.000548	0.00127	CcSEcCtD
Lenalidomide—Flushing—Pentoxifylline—malaria	0.000547	0.00127	CcSEcCtD
Lenalidomide—Vertigo—Dapsone—malaria	0.000539	0.00125	CcSEcCtD
Lenalidomide—Vision blurred—Quinidine—malaria	0.000536	0.00125	CcSEcCtD
Lenalidomide—Vision blurred—Quinine—malaria	0.000536	0.00125	CcSEcCtD
Lenalidomide—Anaemia—Clindamycin—malaria	0.000536	0.00125	CcSEcCtD
Lenalidomide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000533	0.0549	CbGpPWpGaD
Lenalidomide—Tremor—Quinine—malaria	0.000533	0.00124	CcSEcCtD
Lenalidomide—Tremor—Quinidine—malaria	0.000533	0.00124	CcSEcCtD
Lenalidomide—Immune system disorder—Quinidine barbiturate—malaria	0.000533	0.00124	CcSEcCtD
Lenalidomide—Immune system disorder—Pentoxifylline—malaria	0.000532	0.00124	CcSEcCtD
Lenalidomide—Mediastinal disorder—Quinidine barbiturate—malaria	0.000532	0.00124	CcSEcCtD
Lenalidomide—Chills—Quinidine barbiturate—malaria	0.000529	0.00123	CcSEcCtD
Lenalidomide—Arrhythmia—Pentoxifylline—malaria	0.000526	0.00122	CcSEcCtD
Lenalidomide—Cough—Dapsone—malaria	0.000523	0.00122	CcSEcCtD
Lenalidomide—Agitation—Quinidine—malaria	0.000523	0.00122	CcSEcCtD
Lenalidomide—Agitation—Quinine—malaria	0.000523	0.00122	CcSEcCtD
Lenalidomide—Vertigo—Clindamycin—malaria	0.000521	0.00121	CcSEcCtD
Lenalidomide—Angioedema—Quinidine—malaria	0.00052	0.00121	CcSEcCtD
Lenalidomide—Angioedema—Quinine—malaria	0.00052	0.00121	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Sulfadiazine—malaria	0.00052	0.00121	CcSEcCtD
Lenalidomide—Leukopenia—Clindamycin—malaria	0.000519	0.00121	CcSEcCtD
Lenalidomide—Mental disorder—Quinidine barbiturate—malaria	0.000517	0.0012	CcSEcCtD
Lenalidomide—Malnutrition—Quinidine barbiturate—malaria	0.000514	0.00119	CcSEcCtD
Lenalidomide—Erythema—Quinidine barbiturate—malaria	0.000514	0.00119	CcSEcCtD
Lenalidomide—Erythema—Pentoxifylline—malaria	0.000513	0.00119	CcSEcCtD
Lenalidomide—Vertigo—Quinine—malaria	0.000511	0.00119	CcSEcCtD
Lenalidomide—Vertigo—Quinidine—malaria	0.000511	0.00119	CcSEcCtD
Lenalidomide—Syncope—Quinine—malaria	0.00051	0.00119	CcSEcCtD
Lenalidomide—Syncope—Quinidine—malaria	0.00051	0.00119	CcSEcCtD
Lenalidomide—Leukopenia—Quinidine—malaria	0.000509	0.00118	CcSEcCtD
Lenalidomide—Leukopenia—Quinine—malaria	0.000509	0.00118	CcSEcCtD
Lenalidomide—Flatulence—Pentoxifylline—malaria	0.000505	0.00117	CcSEcCtD
Lenalidomide—Urticaria—Sulfadiazine—malaria	0.000505	0.00117	CcSEcCtD
Lenalidomide—Tension—Quinidine barbiturate—malaria	0.000504	0.00117	CcSEcCtD
Lenalidomide—Tension—Pentoxifylline—malaria	0.000503	0.00117	CcSEcCtD
Lenalidomide—Palpitations—Quinidine—malaria	0.000503	0.00117	CcSEcCtD
Lenalidomide—Palpitations—Quinine—malaria	0.000503	0.00117	CcSEcCtD
Lenalidomide—Abdominal pain—Sulfadiazine—malaria	0.000503	0.00117	CcSEcCtD
Lenalidomide—Body temperature increased—Sulfadiazine—malaria	0.000503	0.00117	CcSEcCtD
Lenalidomide—Dysgeusia—Pentoxifylline—malaria	0.000502	0.00117	CcSEcCtD
Lenalidomide—Hypertension—Clindamycin—malaria	0.000501	0.00116	CcSEcCtD
Lenalidomide—Loss of consciousness—Quinine—malaria	0.0005	0.00116	CcSEcCtD
Lenalidomide—Loss of consciousness—Quinidine—malaria	0.0005	0.00116	CcSEcCtD
Lenalidomide—Nervousness—Quinidine barbiturate—malaria	0.000499	0.00116	CcSEcCtD
Lenalidomide—Nervousness—Pentoxifylline—malaria	0.000498	0.00116	CcSEcCtD
Lenalidomide—Back pain—Pentoxifylline—malaria	0.000496	0.00115	CcSEcCtD
Lenalidomide—Muscle spasms—Pentoxifylline—malaria	0.000493	0.00115	CcSEcCtD
Lenalidomide—Discomfort—Clindamycin—malaria	0.000488	0.00113	CcSEcCtD
Lenalidomide—Chest pain—Quinidine—malaria	0.000485	0.00113	CcSEcCtD
Lenalidomide—Myalgia—Quinine—malaria	0.000485	0.00113	CcSEcCtD
Lenalidomide—Chest pain—Quinine—malaria	0.000485	0.00113	CcSEcCtD
Lenalidomide—Myalgia—Quinidine—malaria	0.000485	0.00113	CcSEcCtD
Lenalidomide—Vision blurred—Quinidine barbiturate—malaria	0.000484	0.00113	CcSEcCtD
Lenalidomide—Vision blurred—Pentoxifylline—malaria	0.000483	0.00112	CcSEcCtD
Lenalidomide—Tremor—Quinidine barbiturate—malaria	0.000481	0.00112	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000481	0.00112	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000481	0.00112	CcSEcCtD
Lenalidomide—Tremor—Pentoxifylline—malaria	0.00048	0.00112	CcSEcCtD
Lenalidomide—Tachycardia—Dapsone—malaria	0.000478	0.00111	CcSEcCtD
Lenalidomide—Ill-defined disorder—Pentoxifylline—malaria	0.000476	0.00111	CcSEcCtD
Lenalidomide—Anaemia—Pentoxifylline—malaria	0.000474	0.0011	CcSEcCtD
Lenalidomide—Agitation—Quinidine barbiturate—malaria	0.000472	0.0011	CcSEcCtD
Lenalidomide—Agitation—Pentoxifylline—malaria	0.000471	0.0011	CcSEcCtD
Lenalidomide—Angioedema—Quinidine barbiturate—malaria	0.000469	0.00109	CcSEcCtD
Lenalidomide—Angioedema—Pentoxifylline—malaria	0.000468	0.00109	CcSEcCtD
Lenalidomide—Hypersensitivity—Sulfadiazine—malaria	0.000468	0.00109	CcSEcCtD
Lenalidomide—Confusional state—Quinine—malaria	0.000468	0.00109	CcSEcCtD
Lenalidomide—Confusional state—Quinidine—malaria	0.000468	0.00109	CcSEcCtD
Lenalidomide—Oedema—Quinidine—malaria	0.000465	0.00108	CcSEcCtD
Lenalidomide—Oedema—Quinine—malaria	0.000465	0.00108	CcSEcCtD
Lenalidomide—Thrombocytopenia—Clindamycin—malaria	0.000464	0.00108	CcSEcCtD
Lenalidomide—Malaise—Pentoxifylline—malaria	0.000462	0.00107	CcSEcCtD
Lenalidomide—Vertigo—Quinidine barbiturate—malaria	0.000461	0.00107	CcSEcCtD
Lenalidomide—Syncope—Quinidine barbiturate—malaria	0.000461	0.00107	CcSEcCtD
Lenalidomide—Leukopenia—Quinidine barbiturate—malaria	0.00046	0.00107	CcSEcCtD
Lenalidomide—Leukopenia—Pentoxifylline—malaria	0.000459	0.00107	CcSEcCtD
Lenalidomide—Shock—Quinine—malaria	0.000457	0.00106	CcSEcCtD
Lenalidomide—Shock—Quinidine—malaria	0.000457	0.00106	CcSEcCtD
Lenalidomide—Nervous system disorder—Quinine—malaria	0.000456	0.00106	CcSEcCtD
Lenalidomide—Nervous system disorder—Quinidine—malaria	0.000456	0.00106	CcSEcCtD
Lenalidomide—Thrombocytopenia—Quinidine—malaria	0.000455	0.00106	CcSEcCtD
Lenalidomide—Thrombocytopenia—Quinine—malaria	0.000455	0.00106	CcSEcCtD
Lenalidomide—Palpitations—Quinidine barbiturate—malaria	0.000454	0.00106	CcSEcCtD
Lenalidomide—Tachycardia—Quinine—malaria	0.000453	0.00105	CcSEcCtD
Lenalidomide—Tachycardia—Quinidine—malaria	0.000453	0.00105	CcSEcCtD
Lenalidomide—Palpitations—Pentoxifylline—malaria	0.000453	0.00105	CcSEcCtD
Lenalidomide—Loss of consciousness—Quinidine barbiturate—malaria	0.000451	0.00105	CcSEcCtD
Lenalidomide—Skin disorder—Quinidine—malaria	0.000451	0.00105	CcSEcCtD
Lenalidomide—Skin disorder—Quinine—malaria	0.000451	0.00105	CcSEcCtD
Lenalidomide—Pruritus—Sulfadiazine—malaria	0.00045	0.00105	CcSEcCtD
Lenalidomide—Hyperhidrosis—Quinine—malaria	0.000449	0.00104	CcSEcCtD
Lenalidomide—Hyperhidrosis—Quinidine—malaria	0.000449	0.00104	CcSEcCtD
Lenalidomide—Anorexia—Quinine—malaria	0.000443	0.00103	CcSEcCtD
Lenalidomide—Anorexia—Quinidine—malaria	0.000443	0.00103	CcSEcCtD
Lenalidomide—Insomnia—Dapsone—malaria	0.000443	0.00103	CcSEcCtD
Lenalidomide—Hypertension—Pentoxifylline—malaria	0.000443	0.00103	CcSEcCtD
Lenalidomide—Hypotension—Clindamycin—malaria	0.000442	0.00103	CcSEcCtD
Lenalidomide—Myalgia—Quinidine barbiturate—malaria	0.000437	0.00102	CcSEcCtD
Lenalidomide—Arthralgia—Quinidine barbiturate—malaria	0.000437	0.00102	CcSEcCtD
Lenalidomide—Chest pain—Quinidine barbiturate—malaria	0.000437	0.00102	CcSEcCtD
Lenalidomide—Chest pain—Pentoxifylline—malaria	0.000437	0.00101	CcSEcCtD
Lenalidomide—Myalgia—Pentoxifylline—malaria	0.000437	0.00101	CcSEcCtD
Lenalidomide—Anxiety—Quinidine barbiturate—malaria	0.000436	0.00101	CcSEcCtD
Lenalidomide—Diarrhoea—Sulfadiazine—malaria	0.000435	0.00101	CcSEcCtD
Lenalidomide—Anxiety—Pentoxifylline—malaria	0.000435	0.00101	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000434	0.00101	CcSEcCtD
Lenalidomide—Hypotension—Quinidine—malaria	0.000434	0.00101	CcSEcCtD
Lenalidomide—Hypotension—Quinine—malaria	0.000434	0.00101	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000434	0.00101	CcSEcCtD
Lenalidomide—Discomfort—Pentoxifylline—malaria	0.000431	0.001	CcSEcCtD
Lenalidomide—Dry mouth—Pentoxifylline—malaria	0.000427	0.000992	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Quinine—malaria	0.000423	0.000984	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Quinidine—malaria	0.000423	0.000984	CcSEcCtD
Lenalidomide—Confusional state—Quinidine barbiturate—malaria	0.000423	0.000983	CcSEcCtD
Lenalidomide—Dyspnoea—Clindamycin—malaria	0.000422	0.000981	CcSEcCtD
Lenalidomide—Confusional state—Pentoxifylline—malaria	0.000422	0.000981	CcSEcCtD
Lenalidomide—Oedema—Quinidine barbiturate—malaria	0.000419	0.000974	CcSEcCtD
Lenalidomide—Oedema—Pentoxifylline—malaria	0.000418	0.000973	CcSEcCtD
Lenalidomide—Dyspepsia—Clindamycin—malaria	0.000417	0.000969	CcSEcCtD
Lenalidomide—Infection—Pentoxifylline—malaria	0.000416	0.000966	CcSEcCtD
Lenalidomide—Dyspnoea—Quinidine—malaria	0.000414	0.000963	CcSEcCtD
Lenalidomide—Dyspnoea—Quinine—malaria	0.000414	0.000963	CcSEcCtD
Lenalidomide—Shock—Quinidine barbiturate—malaria	0.000412	0.000959	CcSEcCtD
Lenalidomide—Shock—Pentoxifylline—malaria	0.000412	0.000957	CcSEcCtD
Lenalidomide—Nervous system disorder—Quinidine barbiturate—malaria	0.000411	0.000956	CcSEcCtD
Lenalidomide—Thrombocytopenia—Quinidine barbiturate—malaria	0.00041	0.000954	CcSEcCtD
Lenalidomide—Thrombocytopenia—Pentoxifylline—malaria	0.00041	0.000952	CcSEcCtD
Lenalidomide—Tachycardia—Quinidine barbiturate—malaria	0.000409	0.000951	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Clindamycin—malaria	0.000409	0.00095	CcSEcCtD
Lenalidomide—Tachycardia—Pentoxifylline—malaria	0.000408	0.000949	CcSEcCtD
Lenalidomide—Fatigue—Clindamycin—malaria	0.000408	0.000949	CcSEcCtD
Lenalidomide—Skin disorder—Quinidine barbiturate—malaria	0.000407	0.000947	CcSEcCtD
Lenalidomide—Skin disorder—Pentoxifylline—malaria	0.000406	0.000945	CcSEcCtD
Lenalidomide—Hyperhidrosis—Quinidine barbiturate—malaria	0.000405	0.000942	CcSEcCtD
Lenalidomide—Pain—Clindamycin—malaria	0.000405	0.000941	CcSEcCtD
Lenalidomide—Constipation—Clindamycin—malaria	0.000405	0.000941	CcSEcCtD
Lenalidomide—Hyperhidrosis—Pentoxifylline—malaria	0.000405	0.00094	CcSEcCtD
Lenalidomide—Vomiting—Sulfadiazine—malaria	0.000404	0.00094	CcSEcCtD
Lenalidomide—Decreased appetite—Quinine—malaria	0.000404	0.000939	CcSEcCtD
Lenalidomide—Decreased appetite—Quinidine—malaria	0.000404	0.000939	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Quinidine—malaria	0.000401	0.000932	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Quinine—malaria	0.000401	0.000932	CcSEcCtD
Lenalidomide—Rash—Sulfadiazine—malaria	0.000401	0.000932	CcSEcCtD
Lenalidomide—Dermatitis—Sulfadiazine—malaria	0.000401	0.000931	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dapsone—malaria	0.0004	0.00093	CcSEcCtD
Lenalidomide—Anorexia—Quinidine barbiturate—malaria	0.0004	0.000929	CcSEcCtD
Lenalidomide—Anorexia—Pentoxifylline—malaria	0.000399	0.000927	CcSEcCtD
Lenalidomide—Headache—Sulfadiazine—malaria	0.000398	0.000926	CcSEcCtD
Lenalidomide—Hypotension—Quinidine barbiturate—malaria	0.000392	0.000911	CcSEcCtD
Lenalidomide—Hypotension—Pentoxifylline—malaria	0.000391	0.000909	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Clindamycin—malaria	0.000387	0.0009	CcSEcCtD
Lenalidomide—Abdominal pain—Dapsone—malaria	0.000387	0.0009	CcSEcCtD
Lenalidomide—Body temperature increased—Dapsone—malaria	0.000387	0.0009	CcSEcCtD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—KDR—malaria	0.000387	0.0398	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Quinidine—malaria	0.000383	0.00089	CcSEcCtD
Lenalidomide—Feeling abnormal—Quinine—malaria	0.000383	0.00089	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000382	0.000888	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000381	0.000886	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Quinine—malaria	0.00038	0.000883	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Quinidine—malaria	0.00038	0.000883	CcSEcCtD
Lenalidomide—Insomnia—Pentoxifylline—malaria	0.000378	0.00088	CcSEcCtD
Lenalidomide—Nausea—Sulfadiazine—malaria	0.000378	0.000878	CcSEcCtD
Lenalidomide—Urticaria—Clindamycin—malaria	0.000376	0.000874	CcSEcCtD
Lenalidomide—TNFSF11—IL6-mediated signaling events—IL6—malaria	0.000376	0.0387	CbGpPWpGaD
Lenalidomide—Body temperature increased—Clindamycin—malaria	0.000374	0.00087	CcSEcCtD
Lenalidomide—Abdominal pain—Clindamycin—malaria	0.000374	0.00087	CcSEcCtD
Lenalidomide—Dyspnoea—Quinidine barbiturate—malaria	0.000374	0.000869	CcSEcCtD
Lenalidomide—Dyspnoea—Pentoxifylline—malaria	0.000373	0.000867	CcSEcCtD
Lenalidomide—Somnolence—Quinidine barbiturate—malaria	0.000373	0.000866	CcSEcCtD
Lenalidomide—Somnolence—Pentoxifylline—malaria	0.000372	0.000865	CcSEcCtD
Lenalidomide—TNFSF11—Differentiation Pathway—IL6—malaria	0.000369	0.038	CbGpPWpGaD
Lenalidomide—Urticaria—Quinine—malaria	0.000369	0.000858	CcSEcCtD
Lenalidomide—Urticaria—Quinidine—malaria	0.000369	0.000858	CcSEcCtD
Lenalidomide—Dyspepsia—Pentoxifylline—malaria	0.000368	0.000856	CcSEcCtD
Lenalidomide—Abdominal pain—Quinidine—malaria	0.000367	0.000854	CcSEcCtD
Lenalidomide—Body temperature increased—Quinine—malaria	0.000367	0.000854	CcSEcCtD
Lenalidomide—Abdominal pain—Quinine—malaria	0.000367	0.000854	CcSEcCtD
Lenalidomide—Body temperature increased—Quinidine—malaria	0.000367	0.000854	CcSEcCtD
Lenalidomide—CDH5—Signaling by VEGF—KDR—malaria	0.000365	0.0376	CbGpPWpGaD
Lenalidomide—Decreased appetite—Quinidine barbiturate—malaria	0.000364	0.000847	CcSEcCtD
Lenalidomide—Decreased appetite—Pentoxifylline—malaria	0.000364	0.000846	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000362	0.000841	CcSEcCtD
Lenalidomide—Pain—Quinidine barbiturate—malaria	0.000358	0.000833	CcSEcCtD
Lenalidomide—Constipation—Quinidine barbiturate—malaria	0.000358	0.000833	CcSEcCtD
Lenalidomide—Constipation—Pentoxifylline—malaria	0.000358	0.000832	CcSEcCtD
Lenalidomide—Hypersensitivity—Clindamycin—malaria	0.000349	0.000811	CcSEcCtD
Lenalidomide—Feeling abnormal—Quinidine barbiturate—malaria	0.000345	0.000803	CcSEcCtD
Lenalidomide—Feeling abnormal—Pentoxifylline—malaria	0.000345	0.000802	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000343	0.000797	CcSEcCtD
Lenalidomide—Hypersensitivity—Quinidine—malaria	0.000342	0.000796	CcSEcCtD
Lenalidomide—Hypersensitivity—Quinine—malaria	0.000342	0.000796	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Pentoxifylline—malaria	0.000342	0.000795	CcSEcCtD
Lenalidomide—Asthenia—Clindamycin—malaria	0.00034	0.00079	CcSEcCtD
Lenalidomide—Pruritus—Clindamycin—malaria	0.000335	0.000779	CcSEcCtD
Lenalidomide—Asthenia—Quinine—malaria	0.000333	0.000775	CcSEcCtD
Lenalidomide—Asthenia—Quinidine—malaria	0.000333	0.000775	CcSEcCtD
Lenalidomide—Urticaria—Quinidine barbiturate—malaria	0.000333	0.000774	CcSEcCtD
Lenalidomide—Urticaria—Pentoxifylline—malaria	0.000332	0.000773	CcSEcCtD
Lenalidomide—Abdominal pain—Quinidine barbiturate—malaria	0.000331	0.00077	CcSEcCtD
Lenalidomide—Body temperature increased—Quinidine barbiturate—malaria	0.000331	0.00077	CcSEcCtD
Lenalidomide—Abdominal pain—Pentoxifylline—malaria	0.000331	0.000769	CcSEcCtD
Lenalidomide—Body temperature increased—Pentoxifylline—malaria	0.000331	0.000769	CcSEcCtD
Lenalidomide—Pruritus—Quinidine—malaria	0.000329	0.000764	CcSEcCtD
Lenalidomide—Pruritus—Quinine—malaria	0.000329	0.000764	CcSEcCtD
Lenalidomide—Diarrhoea—Clindamycin—malaria	0.000324	0.000753	CcSEcCtD
Lenalidomide—Diarrhoea—Quinidine—malaria	0.000318	0.000739	CcSEcCtD
Lenalidomide—Diarrhoea—Quinine—malaria	0.000318	0.000739	CcSEcCtD
Lenalidomide—Dizziness—Clindamycin—malaria	0.000313	0.000728	CcSEcCtD
Lenalidomide—Vomiting—Dapsone—malaria	0.000311	0.000723	CcSEcCtD
Lenalidomide—Hypersensitivity—Quinidine barbiturate—malaria	0.000309	0.000718	CcSEcCtD
Lenalidomide—Hypersensitivity—Pentoxifylline—malaria	0.000308	0.000717	CcSEcCtD
Lenalidomide—Dizziness—Quinine—malaria	0.000307	0.000714	CcSEcCtD
Lenalidomide—Dizziness—Quinidine—malaria	0.000307	0.000714	CcSEcCtD
Lenalidomide—Headache—Dapsone—malaria	0.000307	0.000713	CcSEcCtD
Lenalidomide—Vomiting—Clindamycin—malaria	0.000301	0.0007	CcSEcCtD
Lenalidomide—Asthenia—Quinidine barbiturate—malaria	0.000301	0.000699	CcSEcCtD
Lenalidomide—Asthenia—Pentoxifylline—malaria	0.0003	0.000698	CcSEcCtD
Lenalidomide—Rash—Clindamycin—malaria	0.000299	0.000694	CcSEcCtD
Lenalidomide—Dermatitis—Clindamycin—malaria	0.000298	0.000693	CcSEcCtD
Lenalidomide—Headache—Clindamycin—malaria	0.000297	0.00069	CcSEcCtD
Lenalidomide—Pruritus—Quinidine barbiturate—malaria	0.000297	0.000689	CcSEcCtD
Lenalidomide—Pruritus—Pentoxifylline—malaria	0.000296	0.000688	CcSEcCtD
Lenalidomide—Vomiting—Quinidine—malaria	0.000295	0.000687	CcSEcCtD
Lenalidomide—Vomiting—Quinine—malaria	0.000295	0.000687	CcSEcCtD
Lenalidomide—Rash—Quinine—malaria	0.000293	0.000681	CcSEcCtD
Lenalidomide—Rash—Quinidine—malaria	0.000293	0.000681	CcSEcCtD
Lenalidomide—Dermatitis—Quinine—malaria	0.000293	0.00068	CcSEcCtD
Lenalidomide—Dermatitis—Quinidine—malaria	0.000293	0.00068	CcSEcCtD
Lenalidomide—Headache—Quinine—malaria	0.000291	0.000676	CcSEcCtD
Lenalidomide—Headache—Quinidine—malaria	0.000291	0.000676	CcSEcCtD
Lenalidomide—Nausea—Dapsone—malaria	0.000291	0.000676	CcSEcCtD
Lenalidomide—Diarrhoea—Quinidine barbiturate—malaria	0.000287	0.000667	CcSEcCtD
Lenalidomide—Diarrhoea—Pentoxifylline—malaria	0.000286	0.000666	CcSEcCtD
Lenalidomide—Nausea—Clindamycin—malaria	0.000281	0.000654	CcSEcCtD
Lenalidomide—Dizziness—Quinidine barbiturate—malaria	0.000277	0.000644	CcSEcCtD
Lenalidomide—Dizziness—Pentoxifylline—malaria	0.000277	0.000643	CcSEcCtD
Lenalidomide—Nausea—Quinidine—malaria	0.000276	0.000641	CcSEcCtD
Lenalidomide—Nausea—Quinine—malaria	0.000276	0.000641	CcSEcCtD
Lenalidomide—Vomiting—Quinidine barbiturate—malaria	0.000267	0.00062	CcSEcCtD
Lenalidomide—Vomiting—Pentoxifylline—malaria	0.000266	0.000618	CcSEcCtD
Lenalidomide—Rash—Quinidine barbiturate—malaria	0.000264	0.000614	CcSEcCtD
Lenalidomide—Dermatitis—Quinidine barbiturate—malaria	0.000264	0.000614	CcSEcCtD
Lenalidomide—Rash—Pentoxifylline—malaria	0.000264	0.000613	CcSEcCtD
Lenalidomide—Dermatitis—Pentoxifylline—malaria	0.000264	0.000613	CcSEcCtD
Lenalidomide—Headache—Quinidine barbiturate—malaria	0.000263	0.00061	CcSEcCtD
Lenalidomide—Headache—Pentoxifylline—malaria	0.000262	0.000609	CcSEcCtD
Lenalidomide—Nausea—Quinidine barbiturate—malaria	0.000249	0.000579	CcSEcCtD
Lenalidomide—Nausea—Pentoxifylline—malaria	0.000249	0.000578	CcSEcCtD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000217	0.0223	CbGpPWpGaD
Lenalidomide—PTGS2—S1P1 pathway—KDR—malaria	0.000208	0.0214	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000206	0.0212	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000202	0.0208	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000193	0.0198	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000184	0.019	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000179	0.0184	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—IL6—malaria	0.000147	0.0152	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—IL6—malaria	0.000139	0.0143	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000121	0.0125	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000119	0.0123	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000119	0.0122	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ACKR1—malaria	0.000118	0.0121	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000116	0.0119	CbGpPWpGaD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000115	0.0118	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000113	0.0116	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000108	0.0111	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—TNF—malaria	9.82e-05	0.0101	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FCGR2A—malaria	9.69e-05	0.00998	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	9.61e-05	0.0099	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TLR9—malaria	9.51e-05	0.00979	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL12B—malaria	8e-05	0.00824	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—IL6—malaria	7.93e-05	0.00816	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	7e-05	0.00721	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	6.59e-05	0.00679	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CRP—malaria	6.37e-05	0.00656	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	6.22e-05	0.0064	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	5.85e-05	0.00603	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL10—malaria	5.85e-05	0.00603	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40LG—malaria	5.85e-05	0.00603	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL4—malaria	5.82e-05	0.006	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL4—malaria	5.69e-05	0.00586	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-B—malaria	5.56e-05	0.00573	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—FAS—malaria	5.24e-05	0.0054	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	5.18e-05	0.00533	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	5.02e-05	0.00517	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	4.84e-05	0.00499	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TLR4—malaria	4.83e-05	0.00497	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	4.67e-05	0.00481	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—ICAM1—malaria	4.63e-05	0.00477	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS2—malaria	4.59e-05	0.00473	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	4.53e-05	0.00466	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CD4—malaria	4.46e-05	0.0046	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IFNG—malaria	4.45e-05	0.00459	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—malaria	3.97e-05	0.00409	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—KDR—malaria	3.78e-05	0.0039	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	3.65e-05	0.00376	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	3.6e-05	0.00371	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IFNG—malaria	3.52e-05	0.00363	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IFNG—malaria	3.44e-05	0.00354	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—malaria	3.14e-05	0.00323	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL2—malaria	3.13e-05	0.00322	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—malaria	3.07e-05	0.00316	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL2—malaria	3.06e-05	0.00315	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—malaria	2.88e-05	0.00297	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DHODH—malaria	2.8e-05	0.00288	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.75e-05	0.00284	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	2.59e-05	0.00267	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.53e-05	0.0026	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL2—malaria	2.45e-05	0.00253	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC4A1—malaria	2.38e-05	0.00245	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—malaria	2.33e-05	0.00239	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—malaria	2.28e-05	0.00235	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DECR1—malaria	2.24e-05	0.0023	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TNF—malaria	2.23e-05	0.00229	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PKLR—malaria	2.15e-05	0.00222	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HBB—malaria	2.02e-05	0.00208	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DHODH—malaria	1.98e-05	0.00204	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—G6PD—malaria	1.92e-05	0.00198	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—malaria	1.84e-05	0.00189	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PKLR—malaria	1.8e-05	0.00186	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC4A1—malaria	1.69e-05	0.00174	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—G6PD—malaria	1.61e-05	0.00166	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	1.59e-05	0.00163	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DECR1—malaria	1.59e-05	0.00163	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.55e-05	0.0016	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—malaria	1.44e-05	0.00149	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HBB—malaria	1.43e-05	0.00148	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—DHFR—malaria	1.36e-05	0.0014	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PKLR—malaria	1.28e-05	0.00132	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HPGDS—malaria	1.23e-05	0.00126	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—G6PD—malaria	1.14e-05	0.00117	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DHFR—malaria	1.14e-05	0.00117	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SCARB1—malaria	1.13e-05	0.00116	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.1e-05	0.00113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HPGDS—malaria	8.69e-06	0.000895	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DHFR—malaria	8.06e-06	0.00083	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SCARB1—malaria	7.98e-06	0.000822	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CD36—malaria	7.06e-06	0.000728	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—malaria	6.93e-06	0.000714	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD4—malaria	5.14e-06	0.000529	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CD36—malaria	5.01e-06	0.000516	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—malaria	2.78e-06	0.000286	CbGpPWpGaD
